Arkolith/Stocks/GANX

GANX · GAIN THERAPEUTICS INC

USCUSIP 36269B105
Institutional Owners
5
13F Value Held
$6.1M
Insider Net (180d)
$0
Recent Filings
0

Institutional Ownership (13F)

5 holders
#FundValueSharesChangeFiling
1Gotham Asset Management, LLC$5.4M245.9KADDEDQ2 2025
2STATE STREET CORP$306K157.5KNEWQ1 2026
3GREENLIGHT CAPITAL INC$242K74.0KHELDQ4 2023
4Point72 Asset Management, L.P.$105K32.5KNEWQ4 2025
5CITADEL ADVISORS LLC$61K31.4KADDEDQ1 2026

Insider Activity (Form 4)

No Form 4 insider transactions on file yet.

Recent Filings

0 shown

No filings captured for this ticker in the live stream yet.

Funds that own GANX also own

CompanyCo-held byCombined value
KENVUE INCKVUE3 funds$2.3B
VIATRIS INCVTRS3 funds$796.0M
TENET HEALTHCARE CORPTHC3 funds$691.0M
GREEN BRICK PARTNERS INCGRBK3 funds$687.8M
FIRST HORIZON CORPORATIONFHN3 funds$598.2M
SPDR GOLD TRGLD3 funds$559.0M
FIRST CTZNS BANCSHARES INC NFCNCA3 funds$504.9M
BRIGHTHOUSE FINL INCBHF3 funds$278.0M
KYNDRYL HLDGS INCKD3 funds$252.4M
GRAPHIC PACKAGING HLDG COGPK3 funds$218.5M

Ranked by how many of GANX's institutional holders also hold each name — a cross-fund conviction signal. Via the MCP server (ticker.co_held).

13F holdings + Form 4 insider transactions + the live filing stream, joined for GANX. Public domain, sourced to SEC EDGAR. Every panel above is one call to the Arkolith API & MCP server.